NeuroAnimation

What NeuroAnimation does

NeuroAnimation operates two physical Brain Growth and Recovery Centers — its New Albany, Ohio headquarters (6530 W Campus Oval, Suite 160) and a newly opened Lexington, Kentucky facility (April 2026) — where it delivers an immersive, instructor-guided brain-growth therapy for individuals with neurological conditions including stroke, Parkinson's disease, traumatic brain injury, Alzheimer's/dementia, ADHD, depression, and age-related cognitive decline. Its core technology is a neuroscience-validated, game-based interface that combines multi-sensory stimulation (visual, auditory, emotional, movement) with high-dose cognitively-enriched exploratory movement to drive neuroplasticity; the company states it is the only therapy in the world proven through MRI to grow key hippocampal regions (CA3 and subiculum) in adults, with a 4-10% volume increase validated at AAIC 2025 and 2x effectiveness versus standard of care in the SMARTS2 randomized controlled trial for acute stroke.

The therapy is delivered in three program formats: a Three Week Bootcamp Intensive (3 hours/day, 5 days/week for 3 weeks), a Twelve Week Part-Time Schedule (1 hour/day, 2 days/week for 12 weeks), and an Adaptive Schedule (1-3 hours/day, 2-4 days/week, 4-12 weeks customized per client). Revenue is generated through quote-based program fees collected during private consultations; pricing is not publicly disclosed. The company has an NPI-registered clinical entity (NPI: 1962374215), is incorporated in Delaware, and reports 1-10 employees led by CEO Dr. Omar Ahmad (formerly on the Johns Hopkins School of Medicine faculty), CTO Promit Roy, COO Gaurav Gupta, and Chief Creative Officer Tom DeSanto.

Go-to-market is direct-to-consumer consultation-based with no telehealth delivery of the core program, complemented by content marketing (Grow Your Brain Podcast), earned media (CES Innovation Awards 2026 Honoree designation), and a multi-university research consortium spanning Johns Hopkins, Columbia, Harvard, UCLA, UCL, and the American Heart Association, whose flagship Stroke journal published a 2025 paper identifying NeuroAnimation's modality as a solution to the evidence-to-practice gap in high-dose rehabilitation. The company has disclosed over $20M in supporting neuroscience research funding and six or more peer-reviewed studies, but has not disclosed funding rounds, financial investors, or revenue figures.

Name

NeuroAnimation

Legal name

NeuroAnimation, Inc.

Website

https://neuroanimation.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

NeuroAnimation operates physical Brain Growth and Recovery Centers delivering an immersive, MRI-validated, game-based neuroplasticity therapy for individuals recovering from stroke, Parkinson's, traumatic brain injury, Alzheimer's, ADHD, depression, and age-related cognitive decline, currently with clinics in Ohio and Kentucky.

Ownership category

akta.pro rank

Product category

Neurological Rehabilitation Services

NAICS

Vocational Rehabilitation Services (6243), Vocational Rehabilitation Services (624310)

SIC

Services-Home Health Care Services (8082)

akta.pro industry

PRIMARYHLAFAFAH

Neurorehabilitation Centers

Healthcare & Life Sciences/Healthcare Providers & Systems/Post-Acute Care & Rehabilitation Facilities

SECONDARYHLADAJAH

Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s)

Healthcare & Life Sciences/Elder Care & Long-Term Care/Rehabilitation & Post-Acute Care Centers (Inpatient/Outpatient)

SECONDARYHLACANAI

Behavioral Health & Neurocognitive Therapeutics (Digital)

Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

SECONDARYHLAKAIAH

Cognitive & Behavioral Neurology (Dementia/Memory Disorders)

Healthcare & Life Sciences/Specialist Medical Practice/Neurology

SECONDARYHSADAIAC

Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)

Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise

Keywords

• Neurological rehabilitation therapy
• Brain recovery programs
• Neuroplasticity therapy
• Stroke recovery services
• Immersive cognitive therapy

Headquarters

HQ city

California

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Therapy Programs: NeuroAnimation offers structured therapy programs (3-week bootcamp intensive, 12-week part-time schedule, adaptive schedules) delivered in-person at their centers. Programs include 1-3 hours of therapy per session with consolidation exercises. Revenue is generated through program fees which are quote-based and discussed during private consultations.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

NeuroAnimation delivers in-person, instructor-guided immersive neuroplasticity therapy at dedicated Brain Growth and Recovery Centers. The therapy uses a game-based interface combining visual, auditory, emotional, and movement-based stimulation to drive hippocampal growth and restore motor and cognitive function in individuals recovering from stroke, Parkinson's disease, traumatic brain injury, Alzheimer's, ADHD, depression, and age-related cognitive decline.

Product overview

NeuroAnimation offers a single unified therapeutic product—their immersive, game-based brain growth therapy—delivered through three program formats: the Three Week Bootcamp Intensive (3 hours/day, 5 days/week for 3 weeks), the Twelve Week Part-Time Schedule (1 hour/day, 2 days/week for 12 weeks), and an Adaptive Schedule (1-3 hours/day, 2-4 days/week, 4-12 weeks customized to client needs). The therapy targets the hippocampus to drive measurable brain growth and improve outcomes for stroke, Parkinson's, TBI, Alzheimer's, ADHD, depression, and age-related cognitive decline. Additionally, the company produces the Grow Your Brain Podcast as a content offering to share client stories and neuroscience insights.

Differentiator

Problem solved

Functional benefit

Products and services

• Three Week Bootcamp Intensive An intensive 3-week in-person therapy program delivering 3 hours of therapy per day, 5 days a week. Each session includes 2 hours of NeuroAnimation therapy and 1 hour of consolidation exercises. Designed for individuals recovering from stroke, TBI, or neurological conditions seeking concentrated rehabilitation outcomes.
• Twelve Week Part-Time Schedule A 12-week in-person therapy program offering 1 hour of therapy per day, 2 days a week, with consolidation exercises completed at home. Designed for individuals who prefer a less intensive schedule while still receiving NeuroAnimation therapy.
• Adaptive Schedule Program A customizable in-person therapy program where clients work with a specialist on a schedule tailored to their needs: 1-3 hours per day, 2-4 days per week, over 4-12 weeks. Each session includes at least 1 hour of NeuroAnimation therapy. Designed for clients with specific scheduling or therapeutic needs.
• NeuroAnimation Brain Growth Therapy (At-Home VR Continuation) Structured at-home VR therapy program available to individuals after completing a center-based NeuroAnimation program. Not available independently - requires completion of center program first. Enables continued neuroplasticity therapy outside the clinic setting.

Quantifiable outcome

• 2x more effective than standard of care for acute stroke (SMARTS2 RCT, Neurorehabilitation and Neural Repair)
• +6 more outcomes

Named customers9 records

Segments8 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core and major.

• Johns Hopkins UniversitycoreStrategic or Co-development Partner · 1 March 2025Lead research institution for SMARTS2 randomized controlled trial published in Neurorehabilitation and Neural Repair. Collaborated on comparing NeuroAnimation against conventional stroke approaches. Dr. Omar Ahmad previously held faculty role at Johns Hopkins School of Medicine. Ongoing research collaboration on neuroplasticity and stroke recovery.
• Columbia UniversitycoreStrategic or Co-development Partner · 1 March 2025Co-investigator institution for SMARTS2 randomized controlled trial comparing NeuroAnimation against standard stroke rehabilitation approaches.
• Harvard Medical School/UniversitymajorStrategic or Co-development Partner · 1 January 2025Co-authored landmark 2025 paper published in Stroke (AHA) examining why high-dose programs are not widely delivered despite strong scientific support. Part of multi-institution research collaboration with Johns Hopkins and UCLA.
• UCLAmajorStrategic or Co-development Partner · 1 January 2025Co-authored 2025 Stroke publication examining the evidence-to-practice gap in high-dose stroke rehabilitation programs.
• American Heart Association (AHA)coreStrategic or Co-development Partner · 1 January 2025NeuroAnimation research published in Stroke journal, AHA's flagship peer-reviewed publication. AHA published landmark study from Harvard/Johns Hopkins/UCLA identifying NeuroAnimation as the type of technology that can close the evidence-to-practice gap in stroke rehabilitation.
• University College London (UCL)majorStrategic or Co-development Partner · 1 January 2024Queen Square Upper Limb Neurorehabilitation Programme - independent research demonstrating high-dose intensive movement programs support progress even 18 months post-stroke. 224 chronic stroke participants showed clinically meaningful progress.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Reflexion Health: Developer of a telehealth/Virtual Exercise Rehabilitation Assistant (VERA) for physical and neurological rehabilitation. Comparable as a smaller, focused emerging player using video/immersive tech to deliver home-based rehabilitation, similar to NeuroAnimation's post-program VR pathway.

Broad incumbents

• ReWalk Robotics: Wearable robotic exoskeleton company serving stroke and spinal-cord-injury rehabilitation markets. Comparable as an established rehabilitation-technology incumbent addressing gait and mobility recovery in similar patient populations.
• Posit Science (BrainHQ): Established commercial brain-training platform with clinically validated cognitive exercises across aging, stroke, and TBI populations. Comparable as a broader digital cognitive-recovery incumbent with peer-reviewed evidence and payer relationships.
• Hinge Health: Large digital musculoskeletal and chronic-pain therapy platform with payer partnerships and at-home delivery model. Comparable as a scaled digital-therapy operator demonstrating the digital-therapeutics business model NeuroAnimation could pursue through its at-home VR extension.
• Ekso Bionics: Robotic exoskeleton developer for stroke and spinal-cord-injury rehabilitation in clinical settings. Comparable as a higher-cost, clinic-based rehabilitation technology provider competing for the same neurological-recovery budgets and patient populations.

Direct peers

• Constant Therapy Health: Digital brain-rehabilitation platform delivering speech, language, and cognitive therapy exercises. Directly comparable as a tech-enabled neurorehab therapy targeting stroke and TBI recovery with published clinical evidence.
• Neuro Rehab VR: VR-based neurorehabilitation system for clinical and home use across stroke, TBI, and other neurological conditions. Closely comparable in the use of immersive technology to drive neuroplasticity-based motor and cognitive recovery.
• Saebo: Specialist provider of stroke rehabilitation products and therapy programs, including functional orthoses and clinician training. Directly comparable as a category-leading brand focused on stroke recovery and upper-limb rehabilitation.
• MindMaze: Digital neurotherapeutics company building immersive, game-like interfaces to assess and treat neurological conditions including stroke and TBI. Comparable on the digital-therapeutic-plus-immersive-interface approach to brain recovery.
• Flint Rehab: Developer of stroke and neuro-recovery devices (e.g., MusicGlove, FitMi) with home and clinical programs. Comparable as a digital neurorehab player combining engaging interfaces with motor-recovery outcomes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@neuroanimation
• LinkedInlinkedin.com/company/neuroanimation

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NeuroAnimation